Association Between Size of Left Ventricle and Long-Term Cardiovascular Events

Yun-Jiu Cheng1, Zi-Li Liao1, Li-Juan Liu2,3

  • 1Department of Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University Guangzhou China.

Insights

Small left ventricle (LV) size is linked to increased cardiovascular disease risk, including heart attack and stroke. This finding suggests LV size is an important prognostic marker for heart health.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Public Health

Background:

  • The prognostic significance of small left ventricle (LV) size and its link to cardiovascular disease (CVD) is not well understood in the general population.
  • Existing research has not clearly defined the association between LV dimensions and adverse cardiovascular outcomes.

Purpose of the Study:

  • To investigate the prognostic value of small left ventricle (LV) size in predicting cardiovascular disease (CVD) risk.
  • To determine the association between LV end-diastolic volume index and major adverse cardiovascular events (MACE).

Main Methods:

  • Utilized UK Biobank data from 39,363 participants who underwent cardiovascular magnetic resonance imaging.
  • Categorized participants into small, normal, and large LV groups based on LV end-diastolic volume index.
  • Employed Cox proportional hazards models to analyze the relationship between LV size and composite cardiovascular outcomes.

Main Results:

  • A small LV was associated with increased risk of MACE (HR 1.24), coronary heart disease (HR 1.29), ischemic stroke (HR 1.53), and all-cause mortality (HR 1.33).
  • A U-shaped relationship was observed between LV end-diastolic volume index and cardiovascular outcomes.
  • Small LV in men showed a significant correlation with adverse cardiovascular events, indicating potential for risk stratification.

Conclusions:

  • Small LV size should be considered a significant prognostic marker for cardiovascular disease (CVD).
  • Further research is needed to understand the mechanisms and develop targeted interventions for individuals with small LV.
  • LV size assessment may enhance cardiovascular risk prediction and stratification strategies.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
44
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
61
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
54
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
46
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.5K